Effects of Recombinant Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor on Platelet Aggregation in Healthy Volunteers
Explore this paper's citation graph
Summary
This study showed that G-CSF administration may lead to platelet hyperaggregability and the enhancing effect of G- CSF on platelet aggregation should be taken into consideration in clinical usage.
- Type
- article
- Published
- 2015-01-01
- Cited by
- 0
- References
- 31
- Access
- Open access
- OpenAlex
- https://openalex.org/W1493098983
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:55019656
Keywords
Granulocyte colony-stimulating factor, Platelet, Granulocyte macrophage colony-stimulating factor, Platelet-rich plasma, Whole blood
References
- In vivo effect of human granulocyte-macrophage colony-stimulating factor on megakaryocytopoiesis.
- Cancer and Thrombosis: from Phlegmasia Alba Dolens to Transgenic Mice
- Platelet Activation by Polymorphonuclear Leukocytes: Role of Cathepsin G and P-Selectin
- Effects of granulocyte colony-stimulating factor on the hemostatic system in healthy volunteers.
- Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia.
- Molecular analysis of the granulocyte colony-stimulating factor receptor.
- Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children.
- Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration
- Identification of a functional receptor for granulocyte colony-stimulating factor on platelets.
- Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on circulating platelets
- Acute arterial thrombosis after escalated‐dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony‐stimulating factor: A possible new recombinant granulocyte colony‐stimulating factor toxicity
- Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease.
- Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans
- Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony‐stimulating factor
- Recombinant human granulocyte colony-stimulating factor (rhG-CSF) promotes in vitro platelet aggregation
- Granulocyte colony-stimulating factor and platelet aggregation.
- G-CSF-Induced Mobilization of Peripheral Blood Stem Cells from Healthy Adults for Allogeneic Transplantation
- Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial
- Propacetamol augments inhibition of platelet function by diclofenac in volunteers.
- Proteolytic Enzyme Levels Are Increased During Granulocyte Colony-Stimulating Factor-Induced Hematopoietic Stem Cell Mobilization in Human Donors but Do Not Predict the Number of Mobilized Stem Cells
Cited by
No citing papers recorded for this paper.
Related papers
- Quality and quantity of granulocytes mobilized by granulocyte colony-stimulating factor alone and collected by the bag method for granulocyte transfusion
- [Granulocyte colony-stimulating factor treatment (G-CSF) of antithyroid drug-induced granulocytopenia: granulocyte count measurement after 4 hours of G-CSF injection is useful for the detection of recovery from granulocytopenia].
- Physiologic and pathologic consequences of granulocyte colony-stimulating factor deficiency
- Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions.
- Usefulness of Granulocyte Count Measurement Four Hours After Injection of Granulocyte Colony-Stimulating Factor for Detecting Recovery from Antithyroid Drug-Induced Granulocytopenia
- Preparing Platelet-Rich Plasma with Whole Blood Harvested Intraoperatively During Spinal Fusion
- MORPHOLOGIC CHANGES OF NEUTROPHILS IN MYELODYSPLASTIC SYNDROME TREATED WITH RECOMBINANT HUMAN GRANULOCYTE COLONY‐STIMULATING FACTOR
- Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia.
- Recombinant canine granulocyte colony-stimulating factor accelerates recovery from cyclophosphamide-induced neutropenia in dogs.